Daniel Lynch
Venture Partner at GV (Google Ventures)
Boston, Massachusetts
Writes $250K – $50M checks · typically $25M
About
Dan Lynch joined GV as an Executive Venture Partner and senior member of the life sciences team, in a newly created role focused on coaching CEOs and executives at emerging life sciences companies, identifying new investments, and mentoring the firm's life sciences team. He has spent decades in biotech as a CFO, CEO, and executive chairman, and has served as a board member or board chair of 16 companies since 2011. His work centers on advising biotech founders on talent, fundraising, and business development.
Invests in
BiotechDigital HealthMedical Devices
Investments
Board seats
2Seventy BioAlpha Omega SPACAvila TherapeuticsBIND BiosciencesBlueprint MedicinesEdimer PharmaceuticalseGenesis BioEmber TherapeuticsNimbus DiscoveryProclara BiosciencesSesen BioSpringWorks TherapeuticsStromedixSurface OncologyXilio Therapeutics
Per the firm's website.
Colleagues at GV (Google Ventures)
Network10
Investors connected to Daniel in public investor directories — a warm-intro map.